Jason Keyes

Jason Keyes serves as Chief Financial Officer at BlossomHill Therapeutics, Inc. since May 2025 and is a member of the Board of Directors and Audit Committee Chair at Actuate Therapeutics, Inc. since August 2024. Previously, Jason Keyes held the position of Chief Financial Officer at Equillium, Inc. from March 2018 to April 2025, leading financial strategies for a biopharmaceutical company. Jason Keyes was also a Board member and Audit Committee Chair at Sesen Bio from February 2020 to March 2023 and Chief Financial Officer at Orexigen Therapeutics from January 2013 to February 2018. Jason Keyes began financial leadership roles as Vice President of Finance and Senior Director of Finance at Orexigen, contributing to strategic planning and operational decisions. Jason Keyes holds an MBA in Finance from UCLA Anderson School of Management and a Master of Science in Civil Engineering from Stanford University.